{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T23:30:23Z","timestamp":1740180623950,"version":"3.37.3"},"reference-count":7,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008719","name":"Movember Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008719","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011851","name":"Kom op tegen kanker","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.euo.2024.02.002","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T02:19:56Z","timestamp":1709086796000},"page":"1152-1153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reply to Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, and Alberto Briganti\u2019s Letter to the Editor re: Piet Ost, Shankar Siva, Sugmund Brabrand, et al. PEACE V\u2014Salvage Treatment of Oligorecurrent Nodal Prostate Cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial. Eur Urol Oncol. In press. https:\/\/doi.org\/10.1016\/j.euo.2023.09.007"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4784-9883","authenticated-orcid":false,"given":"Thomas","family":"Zilli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piet","family":"Ost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2024.02.002_b0005","doi-asserted-by":"crossref","unstructured":"Ost P, Siva S, Brabrand S, et al. PEACE V\u2014Salvage Treatment of Oligorecurrent Nodal Prostate Cancer Metastases (STORM): acute toxicity of a randomized phase 2 trial. Eur Urol Oncol. In press. https:\/\/doi.org\/10.1016\/j.euo.2023.09.007.","DOI":"10.1016\/j.euo.2023.09.007"},{"key":"10.1016\/j.euo.2024.02.002_b0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.euo.2021.10.002","article-title":"Toxicity and efficacy of local ablative, image-guided radiotherapy in gallium-68 prostate-specific membrane antigen targeted positron emission tomography-staged, castration-sensitive oligometastatic prostate cancer: the OLI-P phase 2 clinical trial","volume":"5","author":"Holscher","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2024.02.002_b0015","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2021.06.010","article-title":"OLIGOPELVIS GETUG P07, a multicenter phase II trial of combined high-dose salvage radiotherapy and hormone therapy in oligorecurrent pelvic node relapses in prostate cancer","volume":"80","author":"Supiot","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.02.002_b0020","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.eururo.2019.07.009","article-title":"Metastasis-directed therapy in treating nodal oligorecurrent prostate cancer: a multi-institutional analysis comparing the outcome and toxicity of stereotactic body radiotherapy and elective nodal radiotherapy","volume":"76","author":"De Bleser","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.02.002_b0025","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.eururo.2020.06.043","article-title":"Long-term outcomes of salvage lymph node dissection for nodal recurrence of prostate cancer after radical prostatectomy: not as good as previously thought","volume":"78","author":"Bravi","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.02.002_b0030","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s12885-020-06911-4","article-title":"PEACE V\u2014Salvage Treatment of Oligorecurrent Nodal Prostate Cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial","volume":"20","author":"De Bruycker","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.euo.2024.02.002_b0035","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/pros.24301","article-title":"Radiating the prostate bed in relapsed oligometastatic prostate cancer: how comprehensive should we be?","volume":"82","author":"Cao","year":"2022","journal-title":"Prostate"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931124000452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931124000452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T23:16:59Z","timestamp":1727219819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931124000452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2588931124000452"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2024.02.002","relation":{},"ISSN":["2588-9311"],"issn-type":[{"type":"print","value":"2588-9311"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reply to Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, and Alberto Briganti\u2019s Letter to the Editor re: Piet Ost, Shankar Siva, Sugmund Brabrand, et al. PEACE V\u2014Salvage Treatment of Oligorecurrent Nodal Prostate Cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial. Eur Urol Oncol. In press. https:\/\/doi.org\/10.1016\/j.euo.2023.09.007","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2024.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}